Study List:

Study 1:
  Title:                    Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Axitinib (AG-013736)|Other: Best Supportive Care|Drug: Placebo|Other: Best Supportive Care
  URL:                      https://ClinicalTrials.gov/show/NCT01210495

Study 2:
  Title:                    Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: OPB-31121|Drug: OPB-31121 phase2
  URL:                      https://ClinicalTrials.gov/show/NCT01406574

Study 3:
  Title:                    Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Sorafenib|Drug: tegafur/uracil (UFUR®)
  URL:                      https://ClinicalTrials.gov/show/NCT00464919

Study 4:
  Title:                    Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: chemoembolization ,Radiofrequency ablation
  URL:                      https://ClinicalTrials.gov/show/NCT00479050

Study 5:
  Title:                    Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Bevacizumab|Drug: Erlotinib
  URL:                      https://ClinicalTrials.gov/show/NCT00287222

Study 6:
  Title:                    Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01890291

Study 7:
  Title:                    Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Sorafenib|Radiation: SIR-Spheres
  URL:                      https://ClinicalTrials.gov/show/NCT00712790

Study 8:
  Title:                    Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Sorafenib|Drug: Yttrium-90 (Y-90)
  URL:                      https://ClinicalTrials.gov/show/NCT00846131

Study 9:
  Title:                    Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006) Sorafenib (Nexavar, BAY43-9006) + Nerison Fatty Ointment Sorafenib (Nexavar, BAY43-9006)+Neribas Fatty Ointment
  URL:                      https://ClinicalTrials.gov/show/NCT01098760

Study 10:
  Title:                    Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Ulinastatin|Drug: Diammonium glycyrrhizinate
  URL:                      https://ClinicalTrials.gov/show/NCT01643447

Study 11:
  Title:                    Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: TACE|Procedure: Laser ablation
  URL:                      https://ClinicalTrials.gov/show/NCT00825669

Study 12:
  Title:                    A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: CF102
  URL:                      https://ClinicalTrials.gov/show/NCT00790218

Study 13:
  Title:                    Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: NGR-hTNF
  URL:                      https://ClinicalTrials.gov/show/NCT00484211

Study 14:
  Title:                    Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: ThermoDox|Drug: 5% Dextrose Solution
  URL:                      https://ClinicalTrials.gov/show/NCT00617981

Study 15:
  Title:                    Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Patupilone
  URL:                      https://ClinicalTrials.gov/show/NCT00273312

Study 16:
  Title:                    A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Oral Pentamidine|Other: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT02210182

Study 17:
  Title:                    Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Cetuximab
  URL:                      https://ClinicalTrials.gov/show/NCT00142428

Study 18:
  Title:                    De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver Carcinoma
  Interventions:            Drug: Sirolimus
  URL:                      https://ClinicalTrials.gov/show/NCT00328770

Study 19:
  Title:                    Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: sustained released 5-FU and sustained released cisplatin|Drug: sustained released 5-FU|Procedure: TACE
  URL:                      https://ClinicalTrials.gov/show/NCT00817895

Study 20:
  Title:                    Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: sorafenib with temsirolimus
  URL:                      https://ClinicalTrials.gov/show/NCT01008917

Study 21:
  Title:                    Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Hepatocellular Carcinoma
  Interventions:            Drug: Octreotide
  URL:                      https://ClinicalTrials.gov/show/NCT00241020

Study 22:
  Title:                    A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: radiotherapy
  URL:                      https://ClinicalTrials.gov/show/NCT00154817

Study 23:
  Title:                    UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Thalidomide|Drug: Tegafur/Uracil
  URL:                      https://ClinicalTrials.gov/show/NCT00519688

Study 24:
  Title:                    Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Sorafenib|Procedure: laser ablation (LA)
  URL:                      https://ClinicalTrials.gov/show/NCT01507064

Study 25:
  Title:                    A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Other: operation;TACE plus PEI
  URL:                      https://ClinicalTrials.gov/show/NCT00825474

Study 26:
  Title:                    Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006)
  URL:                      https://ClinicalTrials.gov/show/NCT01539681

Study 27:
  Title:                    Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: balloon catheter
  URL:                      https://ClinicalTrials.gov/show/NCT00826384

Study 28:
  Title:                    the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Stage I Hepatocellular Carcinoma|Stage II Hepatocellular Carcinoma
  Interventions:            Drug: the ginsenoside Rg3|Drug: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT01717066

Study 29:
  Title:                    Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: transcatheter arterial chemoembolization
  URL:                      https://ClinicalTrials.gov/show/NCT00646100

Study 30:
  Title:                    Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Biological: SOM230
  URL:                      https://ClinicalTrials.gov/show/NCT01639352

Study 31:
  Title:                    Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Adjuvant group
  URL:                      https://ClinicalTrials.gov/show/NCT01088581

Study 32:
  Title:                    Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Recurrent Hepatocellular Carcinoma
  Interventions:            Procedure: laparoscopic resection
  URL:                      https://ClinicalTrials.gov/show/NCT02613156

Study 33:
  Title:                    A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Biological: Placebo|Biological: Ramucirumab DP (IMC-1121B)|Other: BSC
  URL:                      https://ClinicalTrials.gov/show/NCT01140347

Study 34:
  Title:                    Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00834028

Study 35:
  Title:                    Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: ADI-PEG 20 (arginine deiminase formulated with polyethylene glycol)|Drug: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT01287585

Study 36:
  Title:                    Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Other: Retrospective analysis of already archived samples
  URL:                      https://ClinicalTrials.gov/show/NCT00911196

Study 37:
  Title:                    Drug-eluting Bead in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: DebDox TACE
  URL:                      https://ClinicalTrials.gov/show/NCT01332669

Study 38:
  Title:                    The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Device: transarterial chemoembolization using a drug-eluting bead
  URL:                      https://ClinicalTrials.gov/show/NCT01259024

Study 39:
  Title:                    Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: hepatectomy combined with lymphadenectomy|Procedure: hepatectomy alone
  URL:                      https://ClinicalTrials.gov/show/NCT02031952

Study 40:
  Title:                    Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Sorafenib|Procedure: Transarterial chemoembolisation (TACE)
  URL:                      https://ClinicalTrials.gov/show/NCT00768937

Study 41:
  Title:                    Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Gemcitabine|Drug: Oxaliplatin|Drug: Bevacizumab
  URL:                      https://ClinicalTrials.gov/show/NCT00142467

Study 42:
  Title:                    Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Other: Positron emission tomography with fludeoxyglucose F 18
  URL:                      https://ClinicalTrials.gov/show/NCT01157013

Study 43:
  Title:                    Hepatocellular Carcinoma Treated With Iodine-125 Implantation
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Carcinoma
  Interventions:            Procedure: Radiofrequency Ablation|Radiation: iodine
  URL:                      https://ClinicalTrials.gov/show/NCT01717729

Study 44:
  Title:                    A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: dovitinib|Drug: sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01232296

Study 45:
  Title:                    Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: BIIB022|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT00956436

Study 46:
  Title:                    Recurrence of Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01520779

Study 47:
  Title:                    Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: Total hemihepatic vascular exclusion|Procedure: Hemihepatic vascular Clamping|Procedure: Pringle's Maneuver
  URL:                      https://ClinicalTrials.gov/show/NCT00827047

Study 48:
  Title:                    Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
  Interventions:            Procedure: Liver resection plus Thrombectomy
  URL:                      https://ClinicalTrials.gov/show/NCT01600196

Study 49:
  Title:                    The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: LMWH|Procedure: TACE
  URL:                      https://ClinicalTrials.gov/show/NCT00827554

Study 50:
  Title:                    4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: 4SC-201|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT00943449

Study 51:
  Title:                    Study of Hepatocellular Carcinoma in Cirrhotic Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01904942

Study 52:
  Title:                    Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Advanced Adult Hepatocellular Carcinoma
  Interventions:            Drug: Everolimus|Drug: Pasireotide
  URL:                      https://ClinicalTrials.gov/show/NCT01488487

Study 53:
  Title:                    Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: surgical resection|Procedure: percutaneous radiationfrequency ablation
  URL:                      https://ClinicalTrials.gov/show/NCT00814242

Study 54:
  Title:                    Procalcitonin in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01518829

Study 55:
  Title:                    A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Advanced Adult Hepatocellular Carcinoma|Hepatocellular Carcinoma Metastatic
  Interventions:            Drug: AZD9150
  URL:                      https://ClinicalTrials.gov/show/NCT01839604

Study 56:
  Title:                    RAD001 in Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: RAD001
  URL:                      https://ClinicalTrials.gov/show/NCT00516165

Study 57:
  Title:                    A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: OPC-18|Drug: cisplatin
  URL:                      https://ClinicalTrials.gov/show/NCT00524498

Study 58:
  Title:                    HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: Hepatic arterial infusion|Procedure: Transarterial chemoembolization|Drug: Folfox Protocol|Drug: TACE Drug Protocol
  URL:                      https://ClinicalTrials.gov/show/NCT03048123

Study 59:
  Title:                    Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: IFN-α2b
  URL:                      https://ClinicalTrials.gov/show/NCT00149565

Study 60:
  Title:                    SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Carcinoma
  Interventions:            Drug: sorafenib|Drug: SIR-Sphere
  URL:                      https://ClinicalTrials.gov/show/NCT01482442

Study 61:
  Title:                    Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Orantinib (TSU-68)
  URL:                      https://ClinicalTrials.gov/show/NCT00784290

Study 62:
  Title:                    XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Hepatocellular Carcinoma
  Interventions:            Drug: AEG35156 antisense IV infusion|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT00882869

Study 63:
  Title:                    Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01481805

Study 64:
  Title:                    Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: AG-013736
  URL:                      https://ClinicalTrials.gov/show/NCT01273662

Study 65:
  Title:                    Tumor Growth Factors in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Biological: tumor growth factor concentration
  URL:                      https://ClinicalTrials.gov/show/NCT00764140

Study 66:
  Title:                    Study of E7080 in Patients With Advanced Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: E7080
  URL:                      https://ClinicalTrials.gov/show/NCT00946153

Study 67:
  Title:                    Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Device: DEBDOX
  URL:                      https://ClinicalTrials.gov/show/NCT02007954

Study 68:
  Title:                    Sorafenib With TACE to Treat Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Sorafenib|Procedure: Transarterial chemoembolisation with doxorubicin
  URL:                      https://ClinicalTrials.gov/show/NCT00478374

Study 69:
  Title:                    GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Hepatocellular Carcinoma
  Interventions:            Drug: Octreotide-LAR, Lanreotide Autogel|Other: Locoregional treatments
  URL:                      https://ClinicalTrials.gov/show/NCT00495846

Study 70:
  Title:                    Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Genetic: Polymorphisms of HSP70 and TNF promoter
  URL:                      https://ClinicalTrials.gov/show/NCT00769535

Study 71:
  Title:                    SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: SGI-110
  URL:                      https://ClinicalTrials.gov/show/NCT01752933

Study 72:
  Title:                    Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Device: TANDEM™
  URL:                      https://ClinicalTrials.gov/show/NCT01798134

Study 73:
  Title:                    Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: sorafenib, TS-1
  URL:                      https://ClinicalTrials.gov/show/NCT01131689

Study 74:
  Title:                    Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Infusional 5-Fluorouracil|Drug: Sorafenib (Bay 43-9006)
  URL:                      https://ClinicalTrials.gov/show/NCT00619541

Study 75:
  Title:                    Analysis of Expression of Specific Markers in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Other: Retrospective analysis of already archived samples
  URL:                      https://ClinicalTrials.gov/show/NCT00858000

Study 76:
  Title:                    Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: Transarterial chemoembolization (TACE)|Procedure: Transarterial chemoembolization (TACE)|Procedure: Transarterial chemoembolization (TACE)
  URL:                      https://ClinicalTrials.gov/show/NCT00493402

Study 77:
  Title:                    Evaluation of Performance of Automatic Fusion for Radiofrequency Ablation of Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Device: Automatic Imaging fusion of ultrasonography and MRI|Device: Manual Imaging fusion of ultrasonography and MRI
  URL:                      https://ClinicalTrials.gov/show/NCT02705118

Study 78:
  Title:                    A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT02061956

Study 79:
  Title:                    Anatomical Resection of the Liver for Hepatocellular Carcinoma: a New Ultrasound Guided Approach
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: IOUS-GUIDED INTRAHEPATIC VESSEL COMPRESSION
  URL:                      https://ClinicalTrials.gov/show/NCT00829335

Study 80:
  Title:                    Siliphos in Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Hepatocellular Carcinoma
  Interventions:            Drug: Silybin
  URL:                      https://ClinicalTrials.gov/show/NCT01129570

Study 81:
  Title:                    Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Sirolimus|Drug: m-TOR inhibitor free
  URL:                      https://ClinicalTrials.gov/show/NCT01374750

Study 82:
  Title:                    Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: CNI, MMF, Steroids, Aza etc. (mTOR inhibitor free)|Drug: Sirolimus
  URL:                      https://ClinicalTrials.gov/show/NCT00355862

Study 83:
  Title:                    Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Artesunate
  URL:                      https://ClinicalTrials.gov/show/NCT02304289

Study 84:
  Title:                    Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: Cytoreductive Surgery|Procedure: TACE
  URL:                      https://ClinicalTrials.gov/show/NCT00820157

Study 85:
  Title:                    A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma (HCC)
  Interventions:            Combination Product: Stereotactic Body Radiation Therapy (SBRT)
  URL:                      https://ClinicalTrials.gov/show/NCT01247298

Study 86:
  Title:                    Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Brivanib
  URL:                      https://ClinicalTrials.gov/show/NCT01540461

Study 87:
  Title:                    Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: DEB TACE|Procedure: SIRT
  URL:                      https://ClinicalTrials.gov/show/NCT01798160

Study 88:
  Title:                    Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Tivantinib|Drug: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT01755767

Study 89:
  Title:                    Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: MB07133 300mg/m2/day|Drug: MB07133 600 mg/m2/day|Drug: MB07133 1200 mg/m2/day|Drug: MB07133 1800 mg/m2/day|Drug: MB07133 2400 mg/m2/day
  URL:                      https://ClinicalTrials.gov/show/NCT00073736

Study 90:
  Title:                    Transarterial Chemoembolization Plus Radiotherapy or Sorafenib in Hepatocellular Carcinoma With Major Vascular Invasion
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Radiation: TACE+EBRT|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01901692

Study 91:
  Title:                    Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Radiation: CT-guided brachytherapy|Procedure: transarterial chemoembolization
  URL:                      https://ClinicalTrials.gov/show/NCT00807300

Study 92:
  Title:                    A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Biological: mapatumumab|Drug: sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT00712855

Study 93:
  Title:                    Standard Treatments of Very-early Stage Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Very-early Stage
  Interventions:            Procedure: RFA|Procedure: MWV|Procedure: PEI
  URL:                      https://ClinicalTrials.gov/show/NCT02728193

Study 94:
  Title:                    Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: TEA with LEM|Procedure: TACE
  URL:                      https://ClinicalTrials.gov/show/NCT00467974

Study 95:
  Title:                    Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: GC33(RO5137382)|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT00976170

Study 96:
  Title:                    Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Adult Hepatocellular Carcinoma
  Interventions:            Drug: G-202
  URL:                      https://ClinicalTrials.gov/show/NCT01777594

Study 97:
  Title:                    Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Portal Vein Tumor Thrombus
  Interventions:            Drug: chemotherapy with endostar|Drug: treatment with CBP and 5-FU|Drug: treatment with endostar, CBP and 5-FU
  URL:                      https://ClinicalTrials.gov/show/NCT00849264

Study 98:
  Title:                    Study of ARQ 197 in Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Hepatocellular Carcinoma
  Interventions:            Drug: ARQ 197
  URL:                      https://ClinicalTrials.gov/show/NCT01656265

Study 99:
  Title:                    Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Radioembolization
  Interventions:            Procedure: TACE|Procedure: radioembolization with Y-90
  URL:                      https://ClinicalTrials.gov/show/NCT02724436

Study 100:
  Title:                    Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Hepatitis B
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT02025842

Study 101:
  Title:                    Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: doxorubicin, superabsorbent polymer microspheres, embolotherapy
  URL:                      https://ClinicalTrials.gov/show/NCT01116635

Study 102:
  Title:                    SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Device: Radioembolisation (SIR-Spheres® microspheres)|Drug: Transarterial Chemoembolisation
  URL:                      https://ClinicalTrials.gov/show/NCT00867750

Study 103:
  Title:                    Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Hepatocellular Carcinoma
  Interventions:            Drug: ABT-869
  URL:                      https://ClinicalTrials.gov/show/NCT00517920

Study 104:
  Title:                    A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Hepatocellular Carcinoma
  Interventions:            Drug: Apatinib
  URL:                      https://ClinicalTrials.gov/show/NCT01192971

Study 105:
  Title:                    Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Hepatocellular Carcinoma
  Interventions:            Drug: Z-208
  URL:                      https://ClinicalTrials.gov/show/NCT00731445

Study 106:
  Title:                    Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Unresectable Hepatocellular Carcinoma
  Interventions:            Drug: Licartin|Procedure: Transcatheter arterial chemoembolization
  URL:                      https://ClinicalTrials.gov/show/NCT00829465

Study 107:
  Title:                    Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Cirrhosis|Hepatocellular Carcinoma
  Interventions:            Drug: ARQ 197
  URL:                      https://ClinicalTrials.gov/show/NCT00802555

Study 108:
  Title:                    First Line Hepato Cellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepato Cellular Carcinoma (HCC)
  Interventions:            Drug: Brivanib|Drug: Placebo|Drug: Sorafenib|Drug: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT00858871

Study 109:
  Title:                    Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Hepatic Metastasis
  Interventions:            Radiation: Palliative RT
  URL:                      https://ClinicalTrials.gov/show/NCT00923897

Study 110:
  Title:                    Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Primary Hepatocellular Carcinoma
  Interventions:            Biological: DC-TC+GM-CSF
  URL:                      https://ClinicalTrials.gov/show/NCT01828762

Study 111:
  Title:                    Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: GADOXETIC ACID
  URL:                      https://ClinicalTrials.gov/show/NCT01575574

Study 112:
  Title:                    Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Hepatocellular Carcinoma
  Interventions:            Device: TheraBionic device
  URL:                      https://ClinicalTrials.gov/show/NCT00534664

Study 113:
  Title:                    Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Unresectable Hepatocellular Carcinoma
  Interventions:            Drug: ARQ 197|Drug: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT00988741

Study 114:
  Title:                    Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma (HCC)
  Interventions:            Procedure: blood sample
  URL:                      https://ClinicalTrials.gov/show/NCT02541149

Study 115:
  Title:                    Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Obstructive Jaundice
  Interventions:            Drug: Photofrin
  URL:                      https://ClinicalTrials.gov/show/NCT01506115

Study 116:
  Title:                    Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma (HCC)
  Interventions:            Other: Sonazoid-enhanced ultrasonography
  URL:                      https://ClinicalTrials.gov/show/NCT02188901

Study 117:
  Title:                    Proton Beam Therapy for Treatment of Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver Cancer|Hepatocellular Carcinoma
  Interventions:            Radiation: Proton radiation therapy
  URL:                      https://ClinicalTrials.gov/show/NCT00614913

Study 118:
  Title:                    Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|CHILD B
  Interventions:            Drug: sorafenib|Drug: Pravastatin|Drug: Sorafenib + Pravastatin|Other: patients receiving best supportive care
  URL:                      https://ClinicalTrials.gov/show/NCT01357486

Study 119:
  Title:                    Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Liver Transplantation
  Interventions:            Genetic: ADV-TK (adenovirus-thymidine kinase enzyme) gene therapy
  URL:                      https://ClinicalTrials.gov/show/NCT00300521

Study 120:
  Title:                    Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Circulating Tumor Cell;|Hepatocellular Carcinoma
  Interventions:            Procedure: transarterial chemoembolization (TACE)
  URL:                      https://ClinicalTrials.gov/show/NCT02032368

Study 121:
  Title:                    Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Localized Non-Resectable Adult Hepatocellular Carcinoma
  Interventions:            Biological: blood samples (5 ml) will be taken|Radiation: Chemoembolization
  URL:                      https://ClinicalTrials.gov/show/NCT02870010

Study 122:
  Title:                    Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Metastases|Hepatocarcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01411579

Study 123:
  Title:                    Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Liver Cancer
  Interventions:            Drug: PHY906|Drug: capecitabine
  URL:                      https://ClinicalTrials.gov/show/NCT00076609

Study 124:
  Title:                    SU011248 in Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Liver Cancer
  Interventions:            Drug: SU011248
  URL:                      https://ClinicalTrials.gov/show/NCT00361309

Study 125:
  Title:                    Mutational Landscape in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               HepatoCellular Carcinoma|Cirrhosis
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT03071458

Study 126:
  Title:                    Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Liver Cancer
  Interventions:            Device: Yttrium-90 microspheres (Therasphere MDS Nordion)
  URL:                      https://ClinicalTrials.gov/show/NCT00910572

Study 127:
  Title:                    Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatoma|Advanced Solid Tumor
  Interventions:            Drug: irinotecan and ON 01910.Na|Drug: oxaliplatin and ON 01910.Na
  URL:                      https://ClinicalTrials.gov/show/NCT00861783

Study 128:
  Title:                    Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Sorafenib Standard Dosing Regimen|Drug: Sorafenib Ramp-Up Regimen
  URL:                      https://ClinicalTrials.gov/show/NCT01203787

Study 129:
  Title:                    An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Liver Disease
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01316679

Study 130:
  Title:                    Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Hepatitis C Virus Chronic Infection
  Interventions:            Biological: CP 675,206
  URL:                      https://ClinicalTrials.gov/show/NCT01008358

Study 131:
  Title:                    Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Hepatitis B
  Interventions:            Procedure: PEIT|Procedure: TOCE|Procedure: TOCE plus PEIT|Procedure: TOCE plus RFA|Dietary Supplement: MGN-3|Drug: Entecavir
  URL:                      https://ClinicalTrials.gov/show/NCT01018381

Study 132:
  Title:                    Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Renal Cell Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01482520

Study 133:
  Title:                    Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatitis|Hepatocellular Carcinomas
  Interventions:            Device: Low intensity amplitude-moduled electromagnetic fields
  URL:                      https://ClinicalTrials.gov/show/NCT01641276

Study 134:
  Title:                    TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Radiation: TheraSphere HUD
  URL:                      https://ClinicalTrials.gov/show/NCT00683631

Study 135:
  Title:                    Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Biological: cytokine-induced killer cell (CIK) treatment
  URL:                      https://ClinicalTrials.gov/show/NCT00769106

Study 136:
  Title:                    Body Composition Analysis in Patients Undergoing Chemoembolization
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01777698

Study 137:
  Title:                    A Study of IMC-A12 in Combination With Sorafenib in Patients With Advanced Cancer of the Liver
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Biological: IMC-A12 (cixutumumab)|Biological: IMC-A12 (cixutumumab)|Drug: sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT00906373

Study 138:
  Title:                    Hepatic Xenetix-CT Perfusion
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Xenetix-CT perfusion imaging
  URL:                      https://ClinicalTrials.gov/show/NCT01639703

Study 139:
  Title:                    Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
  Interventions:            Procedure: Preoprative TACE|Procedure: Liver resection plus Thrombectomy
  URL:                      https://ClinicalTrials.gov/show/NCT01952353

Study 140:
  Title:                    Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatitis B|Hepatocellular Carcinoma|Chronic Liver Disease
  Interventions:            Genetic: Polymorphism of IL-1 beta and TNF-alpha
  URL:                      https://ClinicalTrials.gov/show/NCT00629486

Study 141:
  Title:                    Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00630240

Study 142:
  Title:                    Radiation Dose Escalation Study for Advanced Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Radiation: 3DCRT/IMRT|Radiation: 3DCRT/IMRT
  URL:                      https://ClinicalTrials.gov/show/NCT00848094

Study 143:
  Title:                    Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Unresectable Non-metastatic Hepatocellular Carcinoma|Child A/B7 Cirrhosis
  Interventions:            Drug: Zavedos®|Other: Blood samples
  URL:                      https://ClinicalTrials.gov/show/NCT02028949

Study 144:
  Title:                    Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Hepatectomy|Chemoembolization
  Interventions:            Procedure: hepatectomy and transcatheter arterial chemoembolization|Procedure: hepatectomy
  URL:                      https://ClinicalTrials.gov/show/NCT00652587

Study 145:
  Title:                    Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: parecoxib sodium
  URL:                      https://ClinicalTrials.gov/show/NCT02552745

Study 146:
  Title:                    Resection for Multiple Hepatocellular Carcinomas (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Multiple Tumors|Cirrhosis
  Interventions:            Procedure: hepatic resection
  URL:                      https://ClinicalTrials.gov/show/NCT01387061

Study 147:
  Title:                    Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: TACE|Procedure: PVE
  URL:                      https://ClinicalTrials.gov/show/NCT00834158

Study 148:
  Title:                    Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Device: E7040
  URL:                      https://ClinicalTrials.gov/show/NCT02269995

Study 149:
  Title:                    Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: Operation|Procedure: Percutaneous ethanol injection therapy
  URL:                      https://ClinicalTrials.gov/show/NCT00357422

Study 150:
  Title:                    MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
  Interventions:            Drug: MEDI-573 (1 of 3 doses)|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01498952

Study 151:
  Title:                    Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Laser Ablation|Portal Vein Tumor Thrombus
  Interventions:            Procedure: LA|Procedure: 3D-CRT
  URL:                      https://ClinicalTrials.gov/show/NCT02724475

Study 152:
  Title:                    PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Other: PET Scan
  URL:                      https://ClinicalTrials.gov/show/NCT01320852

Study 153:
  Title:                    Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Biological: PACOX
  URL:                      https://ClinicalTrials.gov/show/NCT02089633

Study 154:
  Title:                    Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Hepatoma|Liver Cancer, Adult|Liver Cell Carcinoma, Adult
  Interventions:            Drug: TKM-080301
  URL:                      https://ClinicalTrials.gov/show/NCT02191878

Study 155:
  Title:                    Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Hepatitis C|Direct Acting Antivirals
  Interventions:            Drug: Direct Acting Antivirals against hepatitis C virus infection
  URL:                      https://ClinicalTrials.gov/show/NCT03197155

Study 156:
  Title:                    STA-9090 in Patients With Advanced Hepatocellular Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: STA-9090
  URL:                      https://ClinicalTrials.gov/show/NCT01665937

Study 157:
  Title:                    Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: ADI-PEG 20
  URL:                      https://ClinicalTrials.gov/show/NCT02101593

Study 158:
  Title:                    HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Radiation: TheraSphere-Yttrium 90 microsphere
  URL:                      https://ClinicalTrials.gov/show/NCT00605150

Study 159:
  Title:                    Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver Cirrhosis|Hepatocellular Carcinoma|Evidence of Liver Transplantation
  Interventions:            Biological: Liver NK cell inoculation
  URL:                      https://ClinicalTrials.gov/show/NCT01147380

Study 160:
  Title:                    LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: LC Bead loaded with doxorubicin
  URL:                      https://ClinicalTrials.gov/show/NCT00877071

Study 161:
  Title:                    Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma (HCC)
  Interventions:            Procedure: transarterial chemoembolization versus the standard treatment with sorafinib
  URL:                      https://ClinicalTrials.gov/show/NCT03007212

Study 162:
  Title:                    Comparison of Microwave and Radiofrequency Ablation for Liver
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Device: microwave ablation|Device: radiofrequency ablation
  URL:                      https://ClinicalTrials.gov/show/NCT02539212

Study 163:
  Title:                    Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Interferon alpha-2b
  URL:                      https://ClinicalTrials.gov/show/NCT00234182

Study 164:
  Title:                    Urea Cream Treatment Sorafenib-Associated HSFR in HCC
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: urea-based cream
  URL:                      https://ClinicalTrials.gov/show/NCT01934829

Study 165:
  Title:                    to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Biological: MG4101
  URL:                      https://ClinicalTrials.gov/show/NCT02008929

Study 166:
  Title:                    Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: Transarterial chemoembolization|Procedure: Percutaneous ethanol injection therapy
  URL:                      https://ClinicalTrials.gov/show/NCT00357474

Study 167:
  Title:                    Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Biological: Immuncell-LC
  URL:                      https://ClinicalTrials.gov/show/NCT00699816

Study 168:
  Title:                    Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Hepatocellular Carcinoma|Recurrent Hepatocellular Carcinoma|Adverse Reaction to Drug|Vascular Endothelial Growth Factor Overexpression
  Interventions:            Drug: thalidomine|Drug: tegafur-uracil
  URL:                      https://ClinicalTrials.gov/show/NCT02447679

Study 169:
  Title:                    Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Neoplasm|Hepatocellular Carcinoma
  Interventions:            Biological: Pegylated Recombinant Human Arginase I
  URL:                      https://ClinicalTrials.gov/show/NCT01092091

Study 170:
  Title:                    Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatic Carcinoma|Chemoembolizaton|Transarterial Embolization
  Interventions:            Procedure: Transarterial embolization
  URL:                      https://ClinicalTrials.gov/show/NCT03163186

Study 171:
  Title:                    A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Hepatocellular Carcinoma|Inoperable Hepatocellular Carcinoma
  Interventions:            Drug: AMG 386|Drug: AMG 386|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT00872014

Study 172:
  Title:                    Study of Pegylated Human Recombinant Arginase for Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Neoplasm|Hepatocellular Carcinoma
  Interventions:            Biological: Pegylated Recombinant Human Arginase I|Drug: Doxorubicin
  URL:                      https://ClinicalTrials.gov/show/NCT00988195

Study 173:
  Title:                    Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Child-Pugh A Hepatocellular Carcinoma
  Interventions:            Drug: Sorafenib + Pravastatin|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01903694

Study 174:
  Title:                    A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Radiation: Liver Irradiation
  URL:                      https://ClinicalTrials.gov/show/NCT01519232

Study 175:
  Title:                    Combination Treatment for Advanced Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Hepatic Portal Vein Tumor Invasion
  Interventions:            Procedure: chemoembolization|Device: endovascular stents implantation|Procedure: iodine-125 seed strand implantation
  URL:                      https://ClinicalTrials.gov/show/NCT02149771

Study 176:
  Title:                    Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer|Hepatocellular Carcinoma
  Interventions:            Procedure: LT|Drug: ADV-TK|Drug: ganciclovir
  URL:                      https://ClinicalTrials.gov/show/NCT02202564

Study 177:
  Title:                    TACE Study-Liver Embolization Perfusion (VGH Radiology LIU)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Unresectable Hepatocellular Carcinoma|Undergoing Chemoembolization and Radioembolization
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT02093104

Study 178:
  Title:                    A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma (HCC)
  Interventions:            Drug: brivanib (active)
  URL:                      https://ClinicalTrials.gov/show/NCT00355238

Study 179:
  Title:                    A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCC
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatitis B Associated Hepatocellular Carcinoma
  Interventions:            Drug: clevudine, Adefovir
  URL:                      https://ClinicalTrials.gov/show/NCT01263002

Study 180:
  Title:                    Preoperative Pain Control in Liver Surgery Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Pain, Postoperative|Hepatocellular Carcinoma
  Interventions:            Drug: Pregabalin|Drug: Placebo (for Pregabalin)
  URL:                      https://ClinicalTrials.gov/show/NCT01923948

Study 181:
  Title:                    Hepatocellular Carcinoma Growth and Molecular Aggressiveness
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Cirrhosis|Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01657695

Study 182:
  Title:                    Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
  Interventions:            Drug: bortezomib|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00077441

Study 183:
  Title:                    Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
  Interventions:            Drug: gefitinib|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00071994

Study 184:
  Title:                    A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Neoplasms, Liver
  Interventions:            Genetic: JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
  URL:                      https://ClinicalTrials.gov/show/NCT00629759

Study 185:
  Title:                    Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Other: PRFA or PMCT|Procedure: surgery
  URL:                      https://ClinicalTrials.gov/show/NCT00822562

Study 186:
  Title:                    Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma|Liver Cancer
  Interventions:            Drug: Bevacizumab (Avastin)|Drug: Erlotinib
  URL:                      https://ClinicalTrials.gov/show/NCT00242502

Study 187:
  Title:                    Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Cancer|Advanced Hepatocellular Carcinoma
  Interventions:            Drug: AZD8055
  URL:                      https://ClinicalTrials.gov/show/NCT00999882

Study 188:
  Title:                    Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: Lenalidomide
  URL:                      https://ClinicalTrials.gov/show/NCT01545804

Study 189:
  Title:                    Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma (HCC)|Living Donor Liver Transplantation
  Interventions:            Procedure: loco regional therapies for HCC
  URL:                      https://ClinicalTrials.gov/show/NCT02990351

Study 190:
  Title:                    Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Celecoxib|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT02961998

Study 191:
  Title:                    Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatitis C, Chronic
  Interventions:            Drug: interferon-alfa-2b and ribavirin
  URL:                      https://ClinicalTrials.gov/show/NCT00375661

Study 192:
  Title:                    Postoperative Adjuvant TACE Treatment in CK18 Positive Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Postoperative Adjuvant TACE|Hepatocellular Carcinoma.
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT02724345

Study 193:
  Title:                    Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Primary Liver Cancer
  Interventions:            Device: Transarterialchemoembolisation (TACE)|Device: DC Bead with Doxorubicin
  URL:                      https://ClinicalTrials.gov/show/NCT00261378

Study 194:
  Title:                    TK-based Suicide Gene Therapy for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Genetic: TK99UN
  URL:                      https://ClinicalTrials.gov/show/NCT00844623

Study 195:
  Title:                    A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Metastatic Hepatocellular Carcinoma|Advanced Liver Cancer
  Interventions:            Drug: Ascorbic Acid + Sorafenib|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01754987

Study 196:
  Title:                    Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib and Gemcitabine
  URL:                      https://ClinicalTrials.gov/show/NCT00703365

Study 197:
  Title:                    Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Somatostatin (octreotide)
  URL:                      https://ClinicalTrials.gov/show/NCT00386984

Study 198:
  Title:                    Targeted Internal Radiation Therapy in Advanced HCC Patients.
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Internal Radiation|Advanced Hepatocellular Carcinoma
  Interventions:            Biological: 131I-chTNT-1/B
  URL:                      https://ClinicalTrials.gov/show/NCT02724267

Study 199:
  Title:                    An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver Neoplasms|Unresectable Hepatocellular Carcinoma
  Interventions:            Drug: Sunitinib (SU011248)
  URL:                      https://ClinicalTrials.gov/show/NCT00247676

Study 200:
  Title:                    Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: Selective Hepatic Vascular Exclusion|Procedure: Pringle's Maneuver
  URL:                      https://ClinicalTrials.gov/show/NCT00820339

Study 201:
  Title:                    Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Cancer
  Interventions:            Radiation: postoperative radiotherapy
  URL:                      https://ClinicalTrials.gov/show/NCT01456156

Study 202:
  Title:                    Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006)
  URL:                      https://ClinicalTrials.gov/show/NCT01411436

Study 203:
  Title:                    Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Recurrent Hepatocellular Carcinoma
  Interventions:            Procedure: TACE|Procedure: Hepatectomy
  URL:                      https://ClinicalTrials.gov/show/NCT02728219

Study 204:
  Title:                    Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver|Cancer
  Interventions:            Drug: Thalidomide, alpha interferon|Drug: Thalidomide, interferon, Octreotide
  URL:                      https://ClinicalTrials.gov/show/NCT00250796

Study 205:
  Title:                    A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: epirubicin and lipiodol
  URL:                      https://ClinicalTrials.gov/show/NCT00820053

Study 206:
  Title:                    A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Licartin (generic name,[131I]metuximab injection)
  URL:                      https://ClinicalTrials.gov/show/NCT00819650

Study 207:
  Title:                    TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer|Portal Vein Thrombosis
  Interventions:            Device: TheraSphere
  URL:                      https://ClinicalTrials.gov/show/NCT01556282

Study 208:
  Title:                    Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Vandetanib|Drug: Vandetanib|Drug: Best Supportive Care
  URL:                      https://ClinicalTrials.gov/show/NCT00508001

Study 209:
  Title:                    Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer|Recurrence
  Interventions:            Other: Recurrence Rate of HCC after surgery|Other: Recurrence Rate of CCA after surgery
  URL:                      https://ClinicalTrials.gov/show/NCT02941861

Study 210:
  Title:                    A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: MM-141
  URL:                      https://ClinicalTrials.gov/show/NCT01733004

Study 211:
  Title:                    A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Chronic Hepatitis C Infection
  Interventions:            Drug: Ombitasvir/Paritaprevir/Ritonavir|Drug: Dasabuvir|Drug: Ribavirin
  URL:                      https://ClinicalTrials.gov/show/NCT02504099

Study 212:
  Title:                    Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006)
  URL:                      https://ClinicalTrials.gov/show/NCT00812175

Study 213:
  Title:                    Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: celecoxib|Drug: epirubicin hydrochloride
  URL:                      https://ClinicalTrials.gov/show/NCT00057980

Study 214:
  Title:                    Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006)
  URL:                      https://ClinicalTrials.gov/show/NCT01908322

Study 215:
  Title:                    Trial of TG4023 Combined With Flucytosine in Liver Tumors
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Biological: MVA-FCU1, flucytosine
  URL:                      https://ClinicalTrials.gov/show/NCT00978107

Study 216:
  Title:                    Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Procedure: 18F-Fluorodeoxyglucose-PET (FDG-PET)|Procedure: 11Carbon-Acetate-PET
  URL:                      https://ClinicalTrials.gov/show/NCT00081094

Study 217:
  Title:                    A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006)
  URL:                      https://ClinicalTrials.gov/show/NCT00044512

Study 218:
  Title:                    Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01549275

Study 219:
  Title:                    PI-88 in Hepatocellular Carcinoma After Hepatectomy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: PI-88
  URL:                      https://ClinicalTrials.gov/show/NCT00247728

Study 220:
  Title:                    Accuracy Assessment for Computer-assisted Surgical Interventions of the Liver
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Liver Cancer
  Interventions:            Other: Abdominal surgery
  URL:                      https://ClinicalTrials.gov/show/NCT01474694

Study 221:
  Title:                    Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Refametinib (BAY86-9766)
  URL:                      https://ClinicalTrials.gov/show/NCT01915589

Study 222:
  Title:                    FLNA in HCC Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT03081637

Study 223:
  Title:                    Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Perflutren Lipid Microspheres|Device: Dynamic Contrast-Enhanced Ultrasound Imaging|Device: Contrast-enhanced Magnetic Resonance Imaging
  URL:                      https://ClinicalTrials.gov/show/NCT03045497

Study 224:
  Title:                    Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               HepatoCellular Carcinoma
  Interventions:            Drug: Trans-arterial chemoembolization (TACE)|Drug: TACE with Drug Eluting Beads procedure
  URL:                      https://ClinicalTrials.gov/show/NCT03007225

Study 225:
  Title:                    A Novel Laparoscopic Hepatectomy Posture, Left Lateral Position Plus Jackknife Position
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: Jackknife posture
  URL:                      https://ClinicalTrials.gov/show/NCT02809287

Study 226:
  Title:                    Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up Study
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Device: Separable clustered electrodes
  URL:                      https://ClinicalTrials.gov/show/NCT02745483

Study 227:
  Title:                    Simo Decoction and Gum Chewing for Bowel Activity
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Dietary Supplement: simo decoction|Other: gum chewing
  URL:                      https://ClinicalTrials.gov/show/NCT02438436

Study 228:
  Title:                    Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: sorafenib, cisplatin, fluorouracil
  URL:                      https://ClinicalTrials.gov/show/NCT00933816

Study 229:
  Title:                    A Trial of Complete Versus Selective HepaticVascular Clamping in Hepatectomy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: Pringle's Maneuver|Procedure: Hemihepatic vascular Clamping|Procedure: Portal vein occlusion
  URL:                      https://ClinicalTrials.gov/show/NCT00851968

Study 230:
  Title:                    Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: Everolimus, Bevacizumab
  URL:                      https://ClinicalTrials.gov/show/NCT00775073

Study 231:
  Title:                    Effect of I/R Injuries by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative Hepatectomy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Procedure: curative resection without Pringle|Procedure: curative resection with Pringle manoeuvre
  URL:                      https://ClinicalTrials.gov/show/NCT00725335

Study 232:
  Title:                    Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Biological: Ramucirumab (IMC-1121B)
  URL:                      https://ClinicalTrials.gov/show/NCT00627042

Study 233:
  Title:                    Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma
  Interventions:            Drug: gadobenate dimeglumine (MultiHance)
  URL:                      https://ClinicalTrials.gov/show/NCT00539253

Study 234:
  Title:                    A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin|Drug: Doxorubicin/Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT00108953

Study 235:
  Title:                    Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Capecitabine in HCC
  URL:                      https://ClinicalTrials.gov/show/NCT00464295

Study 236:
  Title:                    Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Biological: oblimersen sodium|Drug: doxorubicin hydrochloride
  URL:                      https://ClinicalTrials.gov/show/NCT00047229

Study 237:
  Title:                    Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Cirrhosis of Liver
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01446666

Study 238:
  Title:                    Hepatocellular Carcinoma and Rheumatoid Arthritis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Other: RA
  URL:                      https://ClinicalTrials.gov/show/NCT02880306

Study 239:
  Title:                    Determination of Autonomic Responses to Exposure to Electromagnetic Fields With Low Energy Modulated Frequency
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Breast Cancer
  Interventions:            Device: Electromagnetic Fields of Low Energy (EEFLE)
  URL:                      https://ClinicalTrials.gov/show/NCT01686412

Study 240:
  Title:                    The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma.
  Interventions:            Dietary Supplement: Vitamin B-6|Dietary Supplement: Coenzyme Q10|Dietary Supplement: Vitamin B-6+Coenzyme Q10|Other: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT01964001

Study 241:
  Title:                    Trans-parenchymal Compressing Suture in Major Liver Resection
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Carcinoma Resectable
  Interventions:            Procedure: TCS
  URL:                      https://ClinicalTrials.gov/show/NCT03215290

Study 242:
  Title:                    Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Arrhythmia|Respiratory Arrest
  Interventions:            Drug: Atropine|Drug: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT00575523

Study 243:
  Title:                    Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Hepatocellular Carcinoma|Advanced Adult Hepatocellular Carcinoma|Localized Non-Resectable Adult Liver Carcinoma|Recurrent Adult Liver Carcinoma
  Interventions:            Biological: Cixutumumab|Other: Laboratory Biomarker Analysis|Drug: Sorafenib Tosylate
  URL:                      https://ClinicalTrials.gov/show/NCT01008566

Study 244:
  Title:                    Laparoscopic Hepatectomy Versus Open Hepatectomy for PHC
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Primary Liver Carcinoma
  Interventions:            Procedure: Open hepatectomy|Procedure: Laparoscope hepatectomy
  URL:                      https://ClinicalTrials.gov/show/NCT02014025

Study 245:
  Title:                    TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: TAC-101
  URL:                      https://ClinicalTrials.gov/show/NCT00077142

Study 246:
  Title:                    Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Refametinib (BAY86-9766)|Drug: Sorafenib (BAY43-9006)
  URL:                      https://ClinicalTrials.gov/show/NCT01915602

Study 247:
  Title:                    Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Liver Disease
  Interventions:            Other: hartmann solution
  URL:                      https://ClinicalTrials.gov/show/NCT02329821

Study 248:
  Title:                    East-West Hepatocellular Carcinoma Study Group
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01237132

Study 249:
  Title:                    TRC105 for Liver Cancer That Has Not Responded to Sorafenib
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatocellular Carcinoma|Hepatocellular Cancer|Carcinoma, Hepatocellular
  Interventions:            Drug: TRC105
  URL:                      https://ClinicalTrials.gov/show/NCT01375569

Study 250:
  Title:                    Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Liver Cancer|Localized Unresectable Liver Cancer
  Interventions:            Drug: sorafenib tosylate|Drug: doxorubicin hydrochloride|Drug: cisplatin|Drug: mitomycin C|Procedure: transarterial chemoembolization|Procedure: hepatic artery embolization
  URL:                      https://ClinicalTrials.gov/show/NCT01042041

Study 251:
  Title:                    Proteomic Analysis of Human Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Procedure: Operation
  URL:                      https://ClinicalTrials.gov/show/NCT01177631

Study 252:
  Title:                    A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Genetic: JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
  URL:                      https://ClinicalTrials.gov/show/NCT00554372

Study 253:
  Title:                    Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma
  Interventions:            Drug: Everolimus|Drug: Everolimus Placebo|Other: Best Supportive Care (BSC)
  URL:                      https://ClinicalTrials.gov/show/NCT01035229

Study 254:
  Title:                    A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Liver Cancer|HCC
  Interventions:            Biological: JX-594 recombinant vaccina GM-CSF|Other: Best Supportive Care
  URL:                      https://ClinicalTrials.gov/show/NCT01387555

Study 255:
  Title:                    Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Compensated Cirrhosis
  Interventions:            Procedure: Ultrasonographic screening
  URL:                      https://ClinicalTrials.gov/show/NCT00190385

Study 256:
  Title:                    Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Nexavar (Sorafenib, BAY43-9006)|Drug: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT00692770

Study 257:
  Title:                    A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular|Liver Neoplasms
  Interventions:            Drug: Talaporfin sodium|Device: Interstitial Light Emitting Diodes|Procedure: Percutaneous placement of device in the liver|Procedure: Standard Care
  URL:                      https://ClinicalTrials.gov/show/NCT00355355

Study 258:
  Title:                    Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Hepatitis B Virus
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00769730

Study 259:
  Title:                    Oxaliplatin in Unresectable Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Oxaliplatin
  URL:                      https://ClinicalTrials.gov/show/NCT00280618

Study 260:
  Title:                    Hepatocellular Carcinoma (HCC)_Torisel_
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Inoperable HCC
  Interventions:            Drug: Torisel
  URL:                      https://ClinicalTrials.gov/show/NCT01251458

Study 261:
  Title:                    Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular|Liver Neoplasms
  Interventions:            Procedure: Photodynamic therapy|Drug: Talaporfin Sodium
  URL:                      https://ClinicalTrials.gov/show/NCT00122876

Study 262:
  Title:                    Testing of ADI-PEG in Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: ADI-PEG 20
  URL:                      https://ClinicalTrials.gov/show/NCT00056992

Study 263:
  Title:                    A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: JX-594 followed by sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01171651

Study 264:
  Title:                    Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular|Hepatitis, Viral, Human
  Interventions:            Drug: 131 I-lipiodol
  URL:                      https://ClinicalTrials.gov/show/NCT00116454

Study 265:
  Title:                    Golgi Protein for HCC Diagnosis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Screening for Hepatocellular Carcinoma
  Interventions:            Diagnostic Test: Serum Golgi Protein 73
  URL:                      https://ClinicalTrials.gov/show/NCT03039322

Study 266:
  Title:                    Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer
  Interventions:            Drug: cediranib maleate|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00238394

Study 267:
  Title:                    A National Registry of Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00178867

Study 268:
  Title:                    A Study of Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Varying Degrees of Renal or Hepatic Function
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Cancer
  Interventions:            Drug: Vismodegib
  URL:                      https://ClinicalTrials.gov/show/NCT01546519

Study 269:
  Title:                    Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma. Hepatocellular
  Interventions:            Radiation: RT and hyperthermia after TACE
  URL:                      https://ClinicalTrials.gov/show/NCT01911000

Study 270:
  Title:                    Dose Escalation Study for Primary Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Radiation: Stereotactic Body Radiation
  URL:                      https://ClinicalTrials.gov/show/NCT00243841

Study 271:
  Title:                    Radiofrequency Versus Laser Ablation for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular|Neoplasms, Liver
  Interventions:            Procedure: percutaneous radiofrequency ablation|Procedure: percutaneous laser ablation
  URL:                      https://ClinicalTrials.gov/show/NCT01096914

Study 272:
  Title:                    Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatitis B Virus
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00912847

Study 273:
  Title:                    Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               HCC
  Interventions:            Drug: Donafenib(200mg)|Drug: Donafenib(300mg)
  URL:                      https://ClinicalTrials.gov/show/NCT02229071

Study 274:
  Title:                    Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Radiation: respiratory gated proton beam radiotherapy
  URL:                      https://ClinicalTrials.gov/show/NCT00662246

Study 275:
  Title:                    Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatectomy|Hepatecellular Carcinoma|Cirrhosis
  Interventions:            Procedure: Hepatectomy
  URL:                      https://ClinicalTrials.gov/show/NCT02056041

Study 276:
  Title:                    Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: BAY73-4506
  URL:                      https://ClinicalTrials.gov/show/NCT01003015

Study 277:
  Title:                    A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006)|Drug: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT00105443

Study 278:
  Title:                    Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular|Intrahepatic Cholangiocarcinoma
  Interventions:            Radiation: Stereotactic radiation
  URL:                      https://ClinicalTrials.gov/show/NCT01668134

Study 279:
  Title:                    A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Biological: GV1001
  URL:                      https://ClinicalTrials.gov/show/NCT00444782

Study 280:
  Title:                    A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Thymalfasin (thymosin alpha-1)|Procedure: Trans arterial chemoembolization (TACE)
  URL:                      https://ClinicalTrials.gov/show/NCT00082082

Study 281:
  Title:                    Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
  Interventions:            Drug: doxorubicin|Drug: bortezomib
  URL:                      https://ClinicalTrials.gov/show/NCT00083226

Study 282:
  Title:                    Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Oxaliplatin|Drug: Fluorouracil|Drug: Leucovorin
  URL:                      https://ClinicalTrials.gov/show/NCT00559455

Study 283:
  Title:                    Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Procedure: interventional therapy
  URL:                      https://ClinicalTrials.gov/show/NCT02449109

Study 284:
  Title:                    Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: idarubicin
  URL:                      https://ClinicalTrials.gov/show/NCT01040559

Study 285:
  Title:                    A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006)|Drug: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT00492752

Study 286:
  Title:                    A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib|Drug: BIBF 1120
  URL:                      https://ClinicalTrials.gov/show/NCT00987935

Study 287:
  Title:                    Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: Gemcitabine and Oxaliplatin
  URL:                      https://ClinicalTrials.gov/show/NCT00250822

Study 288:
  Title:                    A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced or Metastatic HCC
  Interventions:            Drug: GC33
  URL:                      https://ClinicalTrials.gov/show/NCT00746317

Study 289:
  Title:                    Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Nintedanib high dose|Drug: Nintedanib low dose|Drug: Nintedanib medium dose|Drug: Nintedanib medium dose|Drug: Nintedanib high dose
  URL:                      https://ClinicalTrials.gov/show/NCT01594125

Study 290:
  Title:                    A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Placebo|Drug: RO5137382
  URL:                      https://ClinicalTrials.gov/show/NCT01507168

Study 291:
  Title:                    Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Chronic Hepatitis C|Neoplasms
  Interventions:            Drug: pegylated interferon alpha 2a and plus ribavirin|Drug: pegylated interferon alpha 2a and plus ribavirin
  URL:                      https://ClinicalTrials.gov/show/NCT00630084

Study 292:
  Title:                    Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006)|Drug: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT00494299

Study 293:
  Title:                    Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Procedure: TACE (Transcatheter Arterial Chemoembolization )
  URL:                      https://ClinicalTrials.gov/show/NCT00919009

Study 294:
  Title:                    Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Recurrence of HCC After LDLT
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01937286

Study 295:
  Title:                    Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Irinotecan plus capecitabine
  URL:                      https://ClinicalTrials.gov/show/NCT00635323

Study 296:
  Title:                    Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib|Drug: BIBF 1120
  URL:                      https://ClinicalTrials.gov/show/NCT01004003

Study 297:
  Title:                    A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: RO5323441|Drug: RO5323441|Drug: sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01308723

Study 298:
  Title:                    Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Oxaliplatin + 5-Fluorouracil/Leucovorin|Drug: Doxorubicin
  URL:                      https://ClinicalTrials.gov/show/NCT00471965

Study 299:
  Title:                    A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Onartuzumab|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01897038

Study 300:
  Title:                    Exploratory Study to Determine Tissue Alterations of Advanced Hepatocellular Carcinoma Induced by Electromagnetic Waves of Low Energy Amplitude Modulated to Specific Frequencies During Imaging Study by MRI
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Primary or Metastatic Tumor in the Liver Parenchyma
  Interventions:            Procedure: Magnetic Resonance + hemodynamic + infusion of gadolinium
  URL:                      https://ClinicalTrials.gov/show/NCT02692365

Study 301:
  Title:                    Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|TACE|Notch1|Rg3
  Interventions:            Procedure: TACE|Drug: Rg3|Other: TACE + Rg3|Procedure: protective therapy
  URL:                      https://ClinicalTrials.gov/show/NCT02724358

Study 302:
  Title:                    Estimation of Functional Liver Reserve Using Cholinesterases
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Cirrhosis|Liver Neoplasm|Liver Disease
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00883454

Study 303:
  Title:                    A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC).
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006)|Drug: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT00855218

Study 304:
  Title:                    Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Immunosuppression|Hepatocellular Carcinoma|Liver Transplantation|Post-operative Complications
  Interventions:            Drug: solu medrol|Drug: a steroid-free immunosuppression protocol
  URL:                      https://ClinicalTrials.gov/show/NCT01137084

Study 305:
  Title:                    Alternative Surgical Policy for Central Liver Tumors
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Colorectal Liver Metastases|Hepatocellular Carcinoma
  Interventions:            Procedure: Ultrasound-guided hepatectomy
  URL:                      https://ClinicalTrials.gov/show/NCT00600522

Study 306:
  Title:                    Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Hepatitis C|Hepatocellular Carcinoma
  Interventions:            Drug: Sofosbuvir|Drug: Ribavirin
  URL:                      https://ClinicalTrials.gov/show/NCT01559844

Study 307:
  Title:                    A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Liver Neoplasms
  Interventions:            Drug: ThermoDox
  URL:                      https://ClinicalTrials.gov/show/NCT00441376

Study 308:
  Title:                    CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Hepatocellular Carcinoma|Liver Cancer|Hepatic Cancer|Liver Neoplasms
  Interventions:            Drug: CS-1008|Drug: sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01033240

Study 309:
  Title:                    IMC-A12 in Treating Patients With Advanced Liver Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
  Interventions:            Biological: cixutumumab|Procedure: computed tomography|Procedure: contrast-enhanced magnetic resonance imaging
  URL:                      https://ClinicalTrials.gov/show/NCT00639509

Study 310:
  Title:                    Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
  Interventions:            Drug: selumetinib|Other: pharmacological study
  URL:                      https://ClinicalTrials.gov/show/NCT00604721

Study 311:
  Title:                    Caphosol in Oral Mucositis Due to Targeted Therapy
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Oral Mucositis|Renal Cell Carcinoma|Hepatocellular Carcinoma|Gastrointestinal Stromal Tumors
  Interventions:            Other: supersaturated calcium-phosphate rinse|Other: sodium chloride 0.9 %
  URL:                      https://ClinicalTrials.gov/show/NCT01265810

Study 312:
  Title:                    The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma;|Radical Hepatic Resection;
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01786980

Study 313:
  Title:                    Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
  Interventions:            Drug: erlotinib hydrochloride|Other: pharmacological study|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00047346

Study 314:
  Title:                    Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
  Interventions:            Drug: belinostat
  URL:                      https://ClinicalTrials.gov/show/NCT00321594

Study 315:
  Title:                    Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Rapamycin
  Interventions:            Drug: Rapamycin
  URL:                      https://ClinicalTrials.gov/show/NCT02724332

Study 316:
  Title:                    Preoperative Oral Supplementation With Branched-Chain Amino Acids (BCAA) Improves Postoperative Quality of Life
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Chronic Liver Disease
  Interventions:            Drug: Aminoleban EN
  URL:                      https://ClinicalTrials.gov/show/NCT00945568

Study 317:
  Title:                    Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatitis B|Hepatocellular Carcinoma
  Interventions:            Biological: Comparator: RECOMBIVAX HB™|Biological: Comparator: Modified process Hepatitis B Vaccine
  URL:                      https://ClinicalTrials.gov/show/NCT00322361

Study 318:
  Title:                    Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Hepatitis C Virus Infection|Liver Cirrhosis|Interferon Treatment|Hepatic Resection
  Interventions:            Drug: Interferon alpha-2b
  URL:                      https://ClinicalTrials.gov/show/NCT00273247

Study 319:
  Title:                    MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Hepatocellular Carcinoma|Advanced Adult Hepatocellular Carcinoma|BCLC Stage 0 Adult Hepatocellular Carcinoma|BCLC Stage A Adult Hepatocellular Carcinoma|BCLC Stage B Adult Hepatocellular Carcinoma|BCLC Stage C Adult Hepatocellular Carcinoma|BCLC Stage D Adult Hepatocellular Carcinoma|Localized Non-Resectable Adult Liver Carcinoma|Localized Resectable Adult Liver Carcinoma
  Interventions:            Drug: Gadoxetate Disodium|Device: Magnetic Resonance Imaging
  URL:                      https://ClinicalTrials.gov/show/NCT02578602

Study 320:
  Title:                    Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Resectable Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
  Interventions:            Drug: sorafenib tosylate|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00844168

Study 321:
  Title:                    Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Hepatocellular Carcinoma|Advanced Adult Hepatocellular Carcinoma|Endometrial Serous Adenocarcinoma|Localized Non-Resectable Adult Liver Carcinoma|Lung Carcinoid Tumor|Malignant Pancreatic Gastrinoma|Malignant Pancreatic Glucagonoma|Malignant Pancreatic Insulinoma|Malignant Pancreatic Somatostatinoma|Metastatic Digestive System Neuroendocrine Tumor G1|Ovarian Carcinosarcoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Surface Papillary Adenocarcinoma|Pancreatic Alpha Cell Adenoma|Pancreatic Beta Cell Adenoma|Pancreatic Delta Cell Adenoma|Pancreatic G-Cell Adenoma|Pancreatic Polypeptide Tumor|Recurrent Adult Liver Carcinoma|Recurrent Digestive System Neuroendocrine Tumor G1|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Neuroendocrine Carcinoma|Recurrent Primary Peritoneal Carcinoma|Recurrent Uterine Corpus Carcinoma|Regional Digestive System Neuroendocrine Tumor G1|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIA Uterine Corpus Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Primary Peritoneal Cancer|Stage IIIC Uterine Corpus Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer|Uterine Carcinosarcoma
  Interventions:            Biological: Bevacizumab|Drug: Temsirolimus
  URL:                      https://ClinicalTrials.gov/show/NCT01010126

Study 322:
  Title:                    Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: sorafenib tosylate, HACE : Doxorubicin Hydrochloride and Mitomycin C|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00949182

Study 323:
  Title:                    Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Procedure: transarterial chemoembolization
  URL:                      https://ClinicalTrials.gov/show/NCT02038296

Study 324:
  Title:                    Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Device: doxorubicin hydrochloride
  URL:                      https://ClinicalTrials.gov/show/NCT00293397

Study 325:
  Title:                    Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: everolimus|Drug: sorafenib tosylate
  URL:                      https://ClinicalTrials.gov/show/NCT01005199

Study 326:
  Title:                    Adult-to-Adult Living Donor Liver Transplantation Study
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Cirrhosis|Hepatitis C|Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00096733

Study 327:
  Title:                    Traditional (Traditional Chemoembolization) TACE Versus Microsphere TACE
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Procedure: Selective TACE via microsphere loaded with Doxorubicin|Procedure: Selective traditional TACE
  URL:                      https://ClinicalTrials.gov/show/NCT00936689

Study 328:
  Title:                    Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Foretinib
  URL:                      https://ClinicalTrials.gov/show/NCT00920192

Study 329:
  Title:                    Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver Cancer
  Interventions:            Drug: Carboplatin|Drug: Cisplatin|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT00875615

Study 330:
  Title:                    Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: alvocidib|Drug: irinotecan hydrochloride
  URL:                      https://ClinicalTrials.gov/show/NCT00087282

Study 331:
  Title:                    Tamoxifen in Treating Patients With Primary Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: tamoxifen citrate
  URL:                      https://ClinicalTrials.gov/show/NCT00003424

Study 332:
  Title:                    Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver Cancer
  Interventions:            Biological: bevacizumab
  URL:                      https://ClinicalTrials.gov/show/NCT00049322

Study 333:
  Title:                    T900607 in Treating Patients With Unresectable Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: T900607
  URL:                      https://ClinicalTrials.gov/show/NCT00054262

Study 334:
  Title:                    Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: megestrol acetate
  URL:                      https://ClinicalTrials.gov/show/NCT00041275

Study 335:
  Title:                    Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Childhood Hepatocellular Carcinoma|Papillary Thyroid Cancer|Previously Treated Childhood Rhabdomyosarcoma|Recurrent Childhood Liver Cancer|Recurrent Childhood Rhabdomyosarcoma|Recurrent Thyroid Cancer|Recurrent Wilms Tumor and Other Childhood Kidney Tumors
  Interventions:            Drug: sorafenib tosylate|Other: pharmacological study|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT01502410

Study 336:
  Title:                    Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Biological: aldesleukin|Drug: doxorubicin hydrochloride
  URL:                      https://ClinicalTrials.gov/show/NCT00004248

Study 337:
  Title:                    Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Radiation: 3-dimensional conformal radiation therapy|Radiation: intensity-modulated radiation therapy|Radiation: stereotactic body radiation therapy
  URL:                      https://ClinicalTrials.gov/show/NCT00777894

Study 338:
  Title:                    Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Metastasis|Cholangiocarcinoma
  Interventions:            Device: Separable cluster electrode (Octopus®)
  URL:                      https://ClinicalTrials.gov/show/NCT02683538

Study 339:
  Title:                    The Second Multicenter Hemophilia Cohort Study
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Decompensation|Hepatocellular Carcinoma|Non-Hodgkin Lymphoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00341705

Study 340:
  Title:                    Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Chronic Liver Disease|HepatoCellular Carcinoma|Liver Fibrosis
  Interventions:            Device: Multispectral CT of the liver
  URL:                      https://ClinicalTrials.gov/show/NCT01825213

Study 341:
  Title:                    Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Colorectal Neoplasms|Hepatocellular Carcinoma|Cholangiocarcinoma
  Interventions:            Drug: oral nutritional supplement rich in eicosapentanoic acid
  URL:                      https://ClinicalTrials.gov/show/NCT00168987

Study 342:
  Title:                    Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: cisplatin|Radiation: brachytherapy|Radiation: yttrium Y 90 glass microspheres
  URL:                      https://ClinicalTrials.gov/show/NCT00109954

Study 343:
  Title:                    Combined HCC-MFCCC
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Carcinoma|Hepatocellular Carcinoma|Cholangiocarcinoma|Surgery
  Interventions:            Procedure: Hepatectomy
  URL:                      https://ClinicalTrials.gov/show/NCT03178409

Study 344:
  Title:                    Epirubicin and Thalidomide in Treating Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: epirubicin hydrochloride|Drug: thalidomide
  URL:                      https://ClinicalTrials.gov/show/NCT00058487

Study 345:
  Title:                    Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Cancer Stem Cells|Postoperative Recurrence and Metastasis|Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT02727673

Study 346:
  Title:                    Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Acquired Immunodeficiency Syndrome Virus|Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted|Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT02113865

Study 347:
  Title:                    Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatitis|Liver Cirrhosis|Hepatocellular Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00679692

Study 348:
  Title:                    Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: octreotide acetate
  URL:                      https://ClinicalTrials.gov/show/NCT00257426

Study 349:
  Title:                    Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: sunitinib malate
  URL:                      https://ClinicalTrials.gov/show/NCT00514228

Study 350:
  Title:                    Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: Rapamycin|Drug: Bevacizumab
  URL:                      https://ClinicalTrials.gov/show/NCT00467194

Study 351:
  Title:                    Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver Cancer
  Interventions:            Biological: cetuximab|Drug: capecitabine|Drug: oxaliplatin
  URL:                      https://ClinicalTrials.gov/show/NCT00483405

Study 352:
  Title:                    Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Biological: bevacizumab|Drug: chemotherapy|Drug: embolization therapy|Procedure: hepatic artery infusion
  URL:                      https://ClinicalTrials.gov/show/NCT00335829

Study 353:
  Title:                    SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: ispinesib
  URL:                      https://ClinicalTrials.gov/show/NCT00095992

Study 354:
  Title:                    Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: docetaxel|Drug: gemcitabine hydrochloride
  URL:                      https://ClinicalTrials.gov/show/NCT00006010

Study 355:
  Title:                    Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: pravastatin sodium|Drug: sorafenib tosylate
  URL:                      https://ClinicalTrials.gov/show/NCT01075555

Study 356:
  Title:                    Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Dietary Supplement: Sho-saiko-to
  URL:                      https://ClinicalTrials.gov/show/NCT00040898

Study 357:
  Title:                    Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver Cancer
  Interventions:            Biological: bevacizumab|Drug: sorafenib tosylate
  URL:                      https://ClinicalTrials.gov/show/NCT00867321

Study 358:
  Title:                    Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: ethiodized oil|Radiation: iodine I 131 ethiodized oil
  URL:                      https://ClinicalTrials.gov/show/NCT00870558

Study 359:
  Title:                    Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver Cancer|Metastatic Cancer
  Interventions:            Drug: cisplatin|Drug: doxorubicin|Drug: mitomycin|Procedure: embolization
  URL:                      https://ClinicalTrials.gov/show/NCT00003907

Study 360:
  Title:                    Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Radiation: yttrium Y 90 glass microspheres|Drug: Doxorubicin
  URL:                      https://ClinicalTrials.gov/show/NCT00956930

Study 361:
  Title:                    Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: doxorubicin hydrochloride|Drug: nolatrexed dihydrochloride
  URL:                      https://ClinicalTrials.gov/show/NCT00012324

Study 362:
  Title:                    Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Adult Primary Hepatocellular Carcinoma|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
  Interventions:            Biological: bevacizumab
  URL:                      https://ClinicalTrials.gov/show/NCT00055692

Study 363:
  Title:                    National Registry and Blood Bank of Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Other: biologic sample preservation procedure|Other: medical chart review|Other: Patient interview
  URL:                      https://ClinicalTrials.gov/show/NCT00482365

Study 364:
  Title:                    Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Tetrathiomolybdate
  URL:                      https://ClinicalTrials.gov/show/NCT00006332

Study 365:
  Title:                    Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer
  Interventions:            Drug: thalidomide|Drug: doxorubicin hydrochloride|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00006016

Study 366:
  Title:                    Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: BAY86-9766 MEK Inhibitor + Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01204177

Study 367:
  Title:                    Vaccine Therapy in Treating Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Biological: AFP gene hepatocellular carcinoma vaccine
  URL:                      https://ClinicalTrials.gov/show/NCT00005629

Study 368:
  Title:                    Vaccine Therapy in Treating Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Biological: AFP
  URL:                      https://ClinicalTrials.gov/show/NCT00022334

Study 369:
  Title:                    DX-8951f in Treating Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: exatecan mesylate
  URL:                      https://ClinicalTrials.gov/show/NCT00004108

Study 370:
  Title:                    Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (BAY-43-9006)
  URL:                      https://ClinicalTrials.gov/show/NCT00490685

Study 371:
  Title:                    Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced HCC
  Interventions:            Drug: Cyclophosphamide
  URL:                      https://ClinicalTrials.gov/show/NCT00396682

Study 372:
  Title:                    Chemotherapy in Treating Children With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: carboplatin|Drug: cisplatin|Drug: doxorubicin hydrochloride|Procedure: conventional surgery
  URL:                      https://ClinicalTrials.gov/show/NCT00003912

Study 373:
  Title:                    The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular|Chronic Hepatitis B
  Interventions:            Procedure: PEIT|Procedure: RFTA
  URL:                      https://ClinicalTrials.gov/show/NCT00397540

Study 374:
  Title:                    Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006)
  URL:                      https://ClinicalTrials.gov/show/NCT01839630

Study 375:
  Title:                    Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Device: Ablation with the NanoKnife Low Energy Direct Current (LEDC) System
  URL:                      https://ClinicalTrials.gov/show/NCT01078415

Study 376:
  Title:                    ISP-TACE Versus TACE for HCC With PVTT
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               HCC|Portal Vein Tumor Thrombosis
  Interventions:            Drug: ethiodized oil; doxorubicin;Gelfoam;|Device: stent; idoine-125
  URL:                      https://ClinicalTrials.gov/show/NCT03108248

Study 377:
  Title:                    An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Lung Cancer|Squamous Cell Carcinoma|Head and Neck Cancer|Hepatic Carcinoma|Renal Cell Carcinoma
  Interventions:            Drug: [F-18] VM4-037
  URL:                      https://ClinicalTrials.gov/show/NCT00884520

Study 378:
  Title:                    A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Brivanib
  URL:                      https://ClinicalTrials.gov/show/NCT00437424

Study 379:
  Title:                    Pilot Study of Effect of Sorafenib on Portal Pressure
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Clinically Significant Portal Hypertension
  Interventions:            Drug: Placebo|Drug: Sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01714609

Study 380:
  Title:                    INSIGHT - Post Marketing Surveillance
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Sorafenib (Nexavar, BAY43-9006)
  URL:                      https://ClinicalTrials.gov/show/NCT00792350

Study 381:
  Title:                    A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: Pemetrexed
  URL:                      https://ClinicalTrials.gov/show/NCT00191412

Study 382:
  Title:                    HCC Response Assessment by MRI After SBRT
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Radiation: SBRT delivers high dose selective irradiation with millimeter precision to a small volume. The Cyberknife® is a robotic SBRT dedicated device that can deliver 100 to 200 photobeams to the target
  URL:                      https://ClinicalTrials.gov/show/NCT03088423

Study 383:
  Title:                    Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01034865

Study 384:
  Title:                    A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Biological: Ramucirumab|Drug: FOLFOX4
  URL:                      https://ClinicalTrials.gov/show/NCT02069041

Study 385:
  Title:                    Effects of Antiviral Therapy on HBV Reactivation
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: Entecavir therapy
  URL:                      https://ClinicalTrials.gov/show/NCT02829359

Study 386:
  Title:                    A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Drug: Capecitabine|Drug: Peginterferon alfa-2a
  URL:                      https://ClinicalTrials.gov/show/NCT02576964

Study 387:
  Title:                    Effect of tDCS on Chronic Abdominal Visceral Pain in HCC Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Abdominal Pain
  Interventions:            Device: transcranial direct current stimulation tDCS
  URL:                      https://ClinicalTrials.gov/show/NCT02928237

Study 388:
  Title:                    Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Device: C-arm CT + DSA as needed|Device: DSA only
  URL:                      https://ClinicalTrials.gov/show/NCT00926536

Study 389:
  Title:                    CIK Treatment for HCC Patient Underwent Radical Resection
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Biological: Cytokine-Induced Killer Cells
  URL:                      https://ClinicalTrials.gov/show/NCT01749865

Study 390:
  Title:                    Adjuvant TACE to Reduce the HCC Recurrence After Resection
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Procedure: Adjuvant TACE|Procedure: Follow-up
  URL:                      https://ClinicalTrials.gov/show/NCT02788526

Study 391:
  Title:                    A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver Cancer
  Interventions:            Drug: Bevacizumab|Procedure: Transarterial chemoembolisation (TACE)
  URL:                      https://ClinicalTrials.gov/show/NCT00576199

Study 392:
  Title:                    Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CT
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               HCC|Liver Tumor
  Interventions:            Procedure: RFA
  URL:                      https://ClinicalTrials.gov/show/NCT02985034

Study 393:
  Title:                    A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carinoma
  Interventions:            Biological: JX-594 recombinant vaccina GM-CSF
  URL:                      https://ClinicalTrials.gov/show/NCT01636284

Study 394:
  Title:                    Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Biological: Peginterferon alfa-2b|Other: Observation (no treatment)
  URL:                      https://ClinicalTrials.gov/show/NCT00759109

Study 395:
  Title:                    Early-Phase Safety of Proton Therapy Equipment
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Malignant Glioma|Hepatocellular Carcinoma|Head and Neck Malignant Tumor|Prostate Cancer
  Interventions:            Radiation: proton therapy
  URL:                      https://ClinicalTrials.gov/show/NCT02315989

Study 396:
  Title:                    Prevention of Recurrent Hepatitis B After Liver Transplantation
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatitis B|Cirrhosis|Acute Liver Failure|Hepatocellular Carcinoma
  Interventions:            Drug: HBIG, Epivir, Hepsera
  URL:                      https://ClinicalTrials.gov/show/NCT00059267

Study 397:
  Title:                    Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
  Interventions:            Biological: bevacizumab|Drug: erlotinib hydrochloride
  URL:                      https://ClinicalTrials.gov/show/NCT00365391

Study 398:
  Title:                    Oxaliplatin in Treating Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
  Interventions:            Drug: oxaliplatin|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00052364

Study 399:
  Title:                    Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Haemangioma|Metastases|Cholangiocellular Carcinoma|Hepatocellular Carcinoma|Focal Nodular Hyperplasia
  Interventions:            Procedure: Shear wave elastography
  URL:                      https://ClinicalTrials.gov/show/NCT02156700

Study 400:
  Title:                    IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Cancer of the Liver|Liver Cancer|Hepatoma|Liver Neoplasms|Biliary Cancer
  Interventions:            Biological: Salmonella typhimurium
  URL:                      https://ClinicalTrials.gov/show/NCT01099631

Study 401:
  Title:                    Long-term Follow-up of HALT-C Sustained Virological Responders
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatitis C|Hepatocellular Carcinoma|Ascites|Variceal Hemorrhage|Death
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00825877

Study 402:
  Title:                    Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatitis C Infection|Viruses|Hepatocellular Carcinoma|Hepatitis, Viral, Human|Liver Cirrhosis
  Interventions:            Biological: Civacir® 10%
  URL:                      https://ClinicalTrials.gov/show/NCT01804829

Study 403:
  Title:                    Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Acute Lymphoblastic Leukemia in Remission|Adult B Acute Lymphoblastic Leukemia|Adult Hepatocellular Carcinoma|Adult Nasal Type Extranodal NK/T-Cell Lymphoma|Adult Solid Neoplasm|Adult T Acute Lymphoblastic Leukemia|Advanced Adult Hepatocellular Carcinoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-Cell Lymphoma|Chronic Lymphocytic Leukemia|Cutaneous B-Cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Hepatosplenic T-Cell Lymphoma|Intraocular Lymphoma|Localized Non-Resectable Adult Liver Carcinoma|Localized Resectable Adult Liver Carcinoma|Lymphomatous Involvement of Non-Cutaneous Extranodal Site|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Nodal Marginal Zone Lymphoma|Progressive Hairy Cell Leukemia Initial Treatment|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Lymphoma|Recurrent Adult Liver Carcinoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-Cell Leukemia/Lymphoma|Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides and Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Small Intestinal Lymphoma|Splenic Marginal Zone Lymphoma|Stage II Small Lymphocytic Lymphoma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-Cell Leukemia/Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Small Lymphocytic Lymphoma|Stage IIIA Mycosis Fungoides and Sezary Syndrome|Stage IIIB Mycosis Fungoides and Sezary Syndrome|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-Cell Leukemia/Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma|Stage IVA Mycosis Fungoides and Sezary Syndrome|Stage IVB Mycosis Fungoides and Sezary Syndrome|T-Cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Hairy Cell Leukemia|Waldenstrom Macroglobulinemia
  Interventions:            Drug: Dasatinib|Other: Pharmacological Study
  URL:                      https://ClinicalTrials.gov/show/NCT00608361

Study 404:
  Title:                    MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Advanced Adult Hepatocellular Carcinoma|Localized Non-Resectable Adult Liver Carcinoma|Recurrent Adult Liver Carcinoma|Recurrent Gallbladder Carcinoma|Stage IV Distal Bile Duct Cancer|Stage IV Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Carcinoma|Unresectable Gallbladder Carcinoma
  Interventions:            Drug: Akt Inhibitor MK2206|Other: Diagnostic Laboratory Biomarker Analysis|Other: Pharmacological Study
  URL:                      https://ClinicalTrials.gov/show/NCT01425879

Study 405:
  Title:                    Asian Phase I Study Of PF-03446962
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Neoplasms
  Interventions:            Drug: PF-03446962
  URL:                      https://ClinicalTrials.gov/show/NCT01337050

Study 406:
  Title:                    A Rapid 10-minute Liver MRI
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Underlying Liver Disease|Hepatitis|Fibrosis of Liver|Cirrhosis With Suspicion of Liver Cancer|Lesion on a Prior Ultrasound, CT or Outside MRI
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01390194

Study 407:
  Title:                    Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatocellular Carcinoma|Primary Liver Cancer|Bile Duct Cancer|Pancreatic Cancer|Gallbladder Cancer|Colorectal Carcinoma|Liver Metastases
  Interventions:            Other: Collaborative Care|Other: Enhanced usual Care
  URL:                      https://ClinicalTrials.gov/show/NCT01640522

Study 408:
  Title:                    Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Anaplastic Astrocytoma|Anaplastic Oligoastrocytoma|Anaplastic Oligodendroglioma|Estrogen Receptor Negative|Estrogen Receptor Positive|Glioblastoma|Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Metastatic Renal Cell Cancer|Recurrent Adult Brain Neoplasm|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Hepatocellular Carcinoma|Recurrent Lung Carcinoma|Recurrent Melanoma|Recurrent Ovarian Carcinoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Uterine Corpus Carcinoma|Resectable Hepatocellular Carcinoma|Sarcoma|Stage IA Breast Cancer|Stage IA Ovarian Cancer|Stage IA Uterine Corpus Cancer|Stage IB Breast Cancer|Stage IB Ovarian Cancer|Stage IB Uterine Corpus Cancer|Stage IC Ovarian Cancer|Stage II Uterine Corpus Cancer|Stage IIA Breast Cancer|Stage IIA Lung Carcinoma|Stage IIA Ovarian Cancer|Stage IIB Breast Cancer|Stage IIB Esophageal Cancer|Stage IIB Lung Carcinoma|Stage IIB Ovarian Cancer|Stage IIB Skin Melanoma|Stage IIC Ovarian Cancer|Stage IIC Skin Melanoma|Stage IIIA Breast Cancer|Stage IIIA Esophageal Cancer|Stage IIIA Lung Carcinoma|Stage IIIA Ovarian Cancer|Stage IIIA Skin Melanoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Breast Cancer|Stage IIIB Esophageal Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Skin Melanoma|Stage IIIB Uterine Corpus Cancer|Stage IIIC Breast Cancer|Stage IIIC Esophageal Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Skin Melanoma|Stage IIIC Uterine Corpus Cancer|Stage IV Bladder Urothelial Carcinoma|Stage IV Esophageal Cancer|Stage IV Ovarian Cancer|Stage IV Prostate Cancer|Stage IV Skin Melanoma|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer
  Interventions:            Biological: DEC-205/NY-ESO-1 Fusion Protein CDX-1401|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Sirolimus
  URL:                      https://ClinicalTrials.gov/show/NCT01522820

Study 409:
  Title:                    A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Non-hematologic Malignancies|Metastatic Melanoma|Breast Cancer|Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer|Hepatocellular Carcinoma
  Interventions:            Drug: ABT-888|Drug: Temozolomide
  URL:                      https://ClinicalTrials.gov/show/NCT00526617

Study 410:
  Title:                    A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Neoplasms
  Interventions:            Drug: ADH -1 (Exherin™)
  URL:                      https://ClinicalTrials.gov/show/NCT00264433

Study 411:
  Title:                    Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Malignant Liver Tumors
  Interventions:            Procedure: irreversible electroporation|Device: nanoknife AngioDynamics US Ltd
  URL:                      https://ClinicalTrials.gov/show/NCT02010801

Study 412:
  Title:                    A Retrospective Review of Malignant Liver Tumors
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00728650

Study 413:
  Title:                    Comparison of Covered and Bare Stent in TIPS
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Cirrhosis
  Interventions:            Device: covered stent|Device: bare stent
  URL:                      https://ClinicalTrials.gov/show/NCT02540382

Study 414:
  Title:                    A Study of MEDI-575 in Patients With Advanced Solid Malignancies
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Solid Malignancies
  Interventions:            Drug: MEDI-575
  URL:                      https://ClinicalTrials.gov/show/NCT01102400

Study 415:
  Title:                    Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Multiple Myeloma|Diffuse Large B-Cell Lymphoma|Glioblastoma Multiforme|Hepatocellular Carcinoma|Non-Small Cell Lung Cancer|Neuroendocrine Tumors of Non-Pancreatic Origin|Hormone Receptor-Positive Breast Cancer
  Interventions:            Drug: CC-223
  URL:                      https://ClinicalTrials.gov/show/NCT01177397

Study 416:
  Title:                    A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Metastatic Breast Cancer [F]|Advanced Breast Cancer|Metastatic Castration Resistant Prostate Cancer|Metastatic Renal Cell Cancer|Non-Small Cell Lung Cancer|Thyroid Cancer|Advanced/Metastatic Non-Small Cell Lung Cancer|Advanced Gastric Cancer|Gastrointestinal Stromal Tumor|Hepatocellular Carcinoma|Pancreatic Islet Cell Carcinoma|Pancreatic Neuroendocrine Tumor
  Interventions:            Drug: sunitinib
  URL:                      https://ClinicalTrials.gov/show/NCT00428220

Study 417:
  Title:                    Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Drug: arsenic trioxide
  URL:                      https://ClinicalTrials.gov/show/NCT00128596

Study 418:
  Title:                    Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Diffuse Astrocytoma|Adult Ependymoblastoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Myxopapillary Ependymoma|Adult Oligodendroglioma|Adult Pilocytic Astrocytoma|Adult Primary Hepatocellular Carcinoma|Adult Subependymoma|Advanced Adult Primary Liver Cancer|Advanced Malignant Mesothelioma|Male Breast Cancer|Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Adult Brain Tumor|Recurrent Adult Primary Liver Cancer|Recurrent Anal Cancer|Recurrent Basal Cell Carcinoma of the Lip|Recurrent Bladder Cancer|Recurrent Breast Cancer|Recurrent Cervical Cancer|Recurrent Colon Cancer|Recurrent Esophageal Cancer|Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Recurrent Lymphoepithelioma of the Nasopharynx|Recurrent Lymphoepithelioma of the Oropharynx|Recurrent Malignant Mesothelioma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Recurrent Mucoepidermoid Carcinoma of the Oral Cavity|Recurrent Non-small Cell Lung Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Pancreatic Cancer|Recurrent Prostate Cancer|Recurrent Rectal Cancer|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Stage II Esophageal Cancer|Stage II Pancreatic Cancer|Stage III Esophageal Cancer|Stage III Pancreatic Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Adenoid Cystic Carcinoma of the Oral Cavity|Stage IV Anal Cancer|Stage IV Basal Cell Carcinoma of the Lip|Stage IV Bladder Cancer|Stage IV Breast Cancer|Stage IV Colon Cancer|Stage IV Esophageal Cancer|Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Stage IV Lymphoepithelioma of the Nasopharynx|Stage IV Lymphoepithelioma of the Oropharynx|Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Stage IV Mucoepidermoid Carcinoma of the Oral Cavity|Stage IV Non-small Cell Lung Cancer|Stage IV Ovarian Epithelial Cancer|Stage IV Pancreatic Cancer|Stage IV Prostate Cancer|Stage IV Rectal Cancer|Stage IV Salivary Gland Cancer|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IV Verrucous Carcinoma of the Larynx|Stage IV Verrucous Carcinoma of the Oral Cavity|Stage IVA Cervical Cancer|Stage IVB Cervical Cancer|Unspecified Adult Solid Tumor, Protocol Specific|Untreated Metastatic Squamous Neck Cancer With Occult Primary
  Interventions:            Drug: erlotinib hydrochloride|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00030498

Study 419:
  Title:                    Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer|Unresectable Gallbladder Cancer
  Interventions:            Drug: lapatinib ditosylate|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00107536

Study 420:
  Title:                    Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer|Unresectable Gallbladder Cancer
  Interventions:            Drug: lapatinib ditosylate|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00101036

Study 421:
  Title:                    Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Childhood Central Nervous System Germ Cell Tumor|Childhood Extragonadal Germ Cell Tumor|Childhood Hepatoblastoma|Childhood Hepatocellular Carcinoma|Childhood High-grade Cerebral Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Malignant Ovarian Germ Cell Tumor|Childhood Malignant Testicular Germ Cell Tumor|Childhood Teratoma|Recurrent Adrenocortical Carcinoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Liver Cancer|Recurrent Childhood Malignant Germ Cell Tumor|Recurrent Childhood Rhabdomyosarcoma|Recurrent Childhood Soft Tissue Sarcoma|Recurrent Childhood Visual Pathway and Hypothalamic Glioma|Recurrent Colon Cancer|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Nasopharyngeal Cancer|Recurrent Neuroblastoma|Recurrent Osteosarcoma|Recurrent Rectal Cancer|Recurrent Renal Cell Cancer
  Interventions:            Drug: oxaliplatin
  URL:                      https://ClinicalTrials.gov/show/NCT00091182

Study 422:
  Title:                    Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adult Primary Cholangiocellular Carcinoma|Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Extrahepatic Bile Duct|Cholangiocarcinoma of the Gallbladder|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer|Unresectable Gallbladder Cancer
  Interventions:            Drug: erlotinib hydrochloride|Other: laboratory biomarker analysis
  URL:                      https://ClinicalTrials.gov/show/NCT00033462

Study 423:
  Title:                    Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adenocarcinoma of the Colon|Adenocarcinoma of the Gallbladder|Adenocarcinoma of the Pancreas|Adenocarcinoma of the Rectum|Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Gallbladder|Diffuse Adenocarcinoma of the Stomach|Intestinal Adenocarcinoma of the Stomach|Male Breast Cancer|Mixed Adenocarcinoma of the Stomach|Ovarian Endometrioid Adenocarcinoma|Paget Disease of the Breast With Intraductal Carcinoma|Paget Disease of the Breast With Invasive Ductal Carcinoma|Recurrent Adult Primary Liver Cancer|Recurrent Breast Cancer|Recurrent Colon Cancer|Recurrent Gallbladder Cancer|Recurrent Gastric Cancer|Recurrent Malignant Testicular Germ Cell Tumor|Recurrent Pancreatic Cancer|Recurrent Rectal Cancer|Recurrent Salivary Gland Cancer|Salivary Gland Adenocarcinoma|Stage II Malignant Testicular Germ Cell Tumor|Stage II Pancreatic Cancer|Stage III Colon Cancer|Stage III Gastric Cancer|Stage III Malignant Testicular Germ Cell Tumor|Stage III Pancreatic Cancer|Stage III Rectal Cancer|Stage III Salivary Gland Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer|Stage IV Colon Cancer|Stage IV Gastric Cancer|Stage IV Pancreatic Cancer|Stage IV Rectal Cancer|Stage IV Salivary Gland Cancer|Thyroid Gland Medullary Carcinoma|Unresectable Gallbladder Cancer
  Interventions:            Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine|Biological: sargramostim|Biological: recombinant fowlpox GM-CSF vaccine adjuvant
  URL:                      https://ClinicalTrials.gov/show/NCT00028496

Study 424:
  Title:                    Advanced Image Guidance Utilized in Liver Surgery
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatocellular
  Interventions:            Device: Advanced Image Guidance
  URL:                      https://ClinicalTrials.gov/show/NCT01666145

Study 425:
  Title:                    Qidong Hepatitis B Intervention Study
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Hepatitis B|Liver Neoplasms|Liver Diseases
  Interventions:            Biological: Hep-V Vax
  URL:                      https://ClinicalTrials.gov/show/NCT00222664

Study 426:
  Title:                    Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer|Metastatic Cancer
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00739167

Study 427:
  Title:                    Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            Biological: recombinant interferon alfa|Drug: thalidomide
  URL:                      https://ClinicalTrials.gov/show/NCT00006006

Study 428:
  Title:                    Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Neoplasm Metastasis
  Interventions:            Drug: Combretastatin A1 Diphosphate (OXi4503)
  URL:                      https://ClinicalTrials.gov/show/NCT00960557

Study 429:
  Title:                    Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
  Recruitment:              Completed
  Study Results:            Has Results
  Conditions:               Liver Neoplasms|Adenoma|Carcinoma|Liver Abscess
  Interventions:            Drug: Gadoxetic Acid Disodium (Eovist, BAY86-4873)
  URL:                      https://ClinicalTrials.gov/show/NCT01043523

Study 430:
  Title:                    A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Solid Tumors With and Without Brain Metastases
  Interventions:            Drug: ANG1005
  URL:                      https://ClinicalTrials.gov/show/NCT00539383

Study 431:
  Title:                    Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Colorectal Cancer|Islet Cell Tumor|Liver Cancer|Metastatic Cancer|Neuroendocrine Carcinoma
  Interventions:            Drug: isolated perfusion|Drug: melphalan|Procedure: conventional surgery
  URL:                      https://ClinicalTrials.gov/show/NCT00019786

Study 432:
  Title:                    Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Cancer
  Interventions:            Biological: therapeutic allogeneic lymphocytes
  URL:                      https://ClinicalTrials.gov/show/NCT00161187

Study 433:
  Title:                    Prospective Liver Study
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Liver Cancer
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT01539993

Study 434:
  Title:                    Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Cirrhosis|Chronic Hepatitis C
  Interventions:            Dietary Supplement: Viusid (nutritional supplement)|Other: Placebo
  URL:                      https://ClinicalTrials.gov/show/NCT00502086

Study 435:
  Title:                    Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               HIV Infection|Liver Failure|Evidence of Liver Transplantation
  Interventions:            Drug: Raltegravir potassium
  URL:                      https://ClinicalTrials.gov/show/NCT01022476

Study 436:
  Title:                    Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Solid Tumors
  Interventions:            Drug: Treatment with ARQ 197 in combination with sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT00827177

Study 437:
  Title:                    Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Advanced Cancers
  Interventions:            Drug: Lenalidomide|Drug: Bevacizumab|Drug: Sorafenib|Drug: Temsirolimus|Drug: Lenalidomide|Drug: Oxaliplatin|Drug: Leucovorin|Drug: 5-fluorouracil
  URL:                      https://ClinicalTrials.gov/show/NCT01183663

Study 438:
  Title:                    Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Solid Tumors|Cancer
  Interventions:            Drug: XL184|Drug: Placebo|Drug: XL184|Drug: XL184
  URL:                      https://ClinicalTrials.gov/show/NCT00940225

Study 439:
  Title:                    Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Adrenocortical Carcinoma|Breast Cancer|Colorectal Cancer|Gastrointestinal Cancer|Kidney Cancer|Liver Cancer|Melanoma (Skin)|Ovarian Cancer|Pancreatic Cancer|Sarcoma
  Interventions:            Biological: colloidal gold-bound tumor necrosis factor|Other: electron microscopy|Other: pharmacological study|Procedure: conventional surgery
  URL:                      https://ClinicalTrials.gov/show/NCT00436410

Study 440:
  Title:                    Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Colorectal Cancer|Depression|Fatigue|Liver Cancer|Pain|Pancreatic Cancer
  Interventions:            Other: medical chart review|Other: questionnaire administration|Other: study of socioeconomic and demographic variables|Procedure: quality-of-life assessment
  URL:                      https://ClinicalTrials.gov/show/NCT00950144

Study 441:
  Title:                    UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Breast Cancer|Colorectal Cancer|Esophageal Cancer|Liver Cancer|Lung Cancer|Ovarian Cancer|Pancreatic Cancer
  Interventions:            Genetic: fluorescence in situ hybridization|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: mass spectrometry
  URL:                      https://ClinicalTrials.gov/show/NCT00900094

Study 442:
  Title:                    Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Esophageal Cancer|Gastric Cancer|Liver Cancer
  Interventions:            Drug: fluorouracil|Drug: irinotecan hydrochloride|Drug: leucovorin calcium|Drug: vorinostat|Other: pharmacological study
  URL:                      https://ClinicalTrials.gov/show/NCT00537121

Study 443:
  Title:                    Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Breast Cancer|Colorectal Cancer|Gallbladder Cancer|Gastric Cancer|Head and Neck Cancer|Liver Cancer|Ovarian Cancer|Pancreatic Cancer|Testicular Germ Cell Tumor
  Interventions:            Biological: TRICOM-CEA(6D)
  URL:                      https://ClinicalTrials.gov/show/NCT00027534

Study 444:
  Title:                    Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Colorectal Cancer|Endometrial Cancer|Head and Neck Cancer|Liver Cancer|Lung Cancer|Melanoma (Skin)|Pancreatic Cancer|Testicular Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol Specific
  Interventions:            Biological: aldesleukin|Biological: ras peptide cancer vaccine|Biological: sargramostim|Drug: DetoxPC
  URL:                      https://ClinicalTrials.gov/show/NCT00019331

Study 445:
  Title:                    Biological Therapy in Treating Patients With Metastatic Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Breast Cancer|Colorectal Cancer|Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Gastric Cancer|Head and Neck Cancer|Liver Cancer|Lung Cancer|Metastatic Cancer|Ovarian Cancer|Pancreatic Cancer|Testicular Germ Cell Tumor
  Interventions:            Biological: CEA RNA-pulsed DC cancer vaccine
  URL:                      https://ClinicalTrials.gov/show/NCT00004604

Study 446:
  Title:                    Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Liver Cancer
  Interventions:            Drug: dolastatin 10
  URL:                      https://ClinicalTrials.gov/show/NCT00003557

Study 447:
  Title:                    Hepatic Monitoring for Pazopanib
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Renal Cell
  Interventions:            Drug: Pazopanib use|Drug: Use of sunitinib, bevacizumab, or sorafenib
  URL:                      https://ClinicalTrials.gov/show/NCT01449825

Study 448:
  Title:                    Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Kidney Cancer|Metastatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific
  Interventions:            Procedure: radiofrequency ablation|Procedure: thermal ablation therapy
  URL:                      https://ClinicalTrials.gov/show/NCT00006255

Study 449:
  Title:                    Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Biliary Tract Cancer
  Interventions:            Drug: Oxaliplatin, Fluorouracil, Leucovorin, Capecitabine
  URL:                      https://ClinicalTrials.gov/show/NCT01572324

Study 450:
  Title:                    Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Colorectal Carcinoma
  Interventions:            
  URL:                      https://ClinicalTrials.gov/show/NCT00588549

Study 451:
  Title:                    A Phase I Study of Pazopanib in Adult Patients With Liver Cancer
  Recruitment:              Completed
  Study Results:            No Results Available
  Conditions:               Carcinoma, Hepatic Cell|Liver Cancer
  Interventions:            Drug: pazopanib
  URL:                      https://ClinicalTrials.gov/show/NCT00370513

